Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ENGNW
ENGENE HOLDINGS INC. WARRANTS
NASDAQ
$0.43
▲ UP 71.90% (0.18)

KEY STATISTICS

Market Cap$22.02 M
52w High$2.10
52w Low$0.25
Dividend Yield—
Frequency—
P/E0.18
Volume2.40K
Shares Out.51.19M

COMPANY

LEADERSHIP

Ronald H. W. Cooper
CHIEF EXECUTIVE
Ronald H. W. Cooper

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 1, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
82

UPCOMING EARNINGS

DateSep 16, 2026
DayWednesday
Rev. Est.—
SEP
16
WED

PRICE

$0.43 ▲ UP 71.90% (+$0.18)
$0.30$0.3812:47 PM12:48 PM12:50 PM12:51 PM12:52 PM12:54 PM12:55 PM0.43

About enGene Holdings Inc. Warrants

https://www.engene.com ↗

enGene Holdings Inc., a clinical-stage biotech founded in 2023 in Canada, develops genetic medicines like EG-70 for mucosal and organ delivery, targeting bladder cancer patients unresponsive to BCG therapy.

INDUSTRY

Biotechnology

A PRODUCT ENGENE HOLDINGS INC. WARRANTS IS KNOWN FOR

Detalimogene Voraplasmid
Detalimogene Voraplasmid

Detalimogene voraplasmid is enGene's lead non-viral gene therapy in clinical trials for NMIBC, administered directly into the bladder to trigger a localized immune response for patients unresponsive to BCG.

COMPETITORS

COMPETITOR
CGON COMPARE
IBRX COMPARE
JNJ COMPARE
MRK COMPARE
TARA COMPARE

RATINGS SNAPSHOT

Overall rating: A+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings3
Price To Book4
Overall Score5

INSIDER TRADES

★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · 13.9K shares
2026-07-16
★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · 105.0K shares
2026-07-16
★
OFFICER: INTERIM CHIEF BUSINESS OFFICER
Chinoporos Constantine
— · 75.0K shares
2026-07-16
★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · —
2026-07-16

SECTORS PEERS

PEERPRICE
ALXO$2.04COMPARE
UNCY$5.63COMPARE
GUTS$0.78COMPARE
DTIL$8.85COMPARE
BMEA$1.37COMPARE
CAMP$4.48COMPARE
HYFT$1.41COMPARE
ATYR$0.50COMPARE